Etid klinik pou Sipwa nan Ocala, FL
6 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Ocala (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Ap rekriteFaz 3
- Renstar Medical Research, Ocala
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Ap rekriteFaz 2
- Renstar Medical Research, Ocala
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Ocala
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- Renstar Medical Research, Ocala
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Renstar Medical Research, Ocala
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Ocala
Etid Sipwa nan lòt vil
- Houston, TX33 etid
- San Antonio, TX33 etid
- Chicago, IL28 etid
- Orlando, FL25 etid
- Miami, FL23 etid
- Las Vegas, NV23 etid
- Dallas, TX20 etid
- Atlanta, GA20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Ocala
- Kansè Poumon ki pa ti selil10 etid
- Maladi fwa steatotik8 etid
- Obèsite7 etid
- Maladi Alzheimer6 etid
- Ensifizyans kadyak5 etid
- BPCO5 etid
- Maladi kadyovaskilè3 etid
- Ateroskleroz3 etid
- Kansè Metastatik3 etid
- Fèbli Kognitif Lejè3 etid
- Maladi fwa3 etid
- Doulè kwonik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.